These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7835785)

  • 21. Primary fallopian tube adenocarcinoma in situ associated with adjuvant tamoxifen therapy for breast carcinoma.
    Sonnendecker HE; Cooper K; Kalian KN
    Gynecol Oncol; 1994 Mar; 52(3):402-7. PubMed ID: 8157199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulosa cell tumor of the ovary after long-term use of tamoxifen and toremifene.
    Tanaka T; Kato T; Ohmichi M
    J Obstet Gynaecol Res; 2012 Dec; 38(12):1379-84. PubMed ID: 22612286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy.
    Okada DH; Rowland JB; Petrovic LM
    Gynecol Oncol; 1999 Dec; 75(3):509-13. PubMed ID: 10600318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrioid adenocarcinoma of the ovary and endometriosis.
    Valenzuela P; Ramos P; Redondo S; Cabrera Y; Alvarez I; Ruiz A
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):83-6. PubMed ID: 16844279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gynecologic tumors in tamoxifen-treated women with breast cancer.
    Seoud MA; Johnson J; Weed JC
    Obstet Gynecol; 1993 Aug; 82(2):165-9. PubMed ID: 8393156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas.
    Altaras MM; Aviram R; Cohen I; Cordoba M; Yarkoni S; Beyth Y
    Gynecol Oncol; 1993 May; 49(2):255-8. PubMed ID: 8504996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer and endometriosis: do we need to be concerned?
    Martin DC
    Semin Reprod Endocrinol; 1997; 15(3):319-24. PubMed ID: 9383841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report.
    Bardi M; Arnoldi E; Pizzocchero G; Pezzica E; Mattioni D; Perotti M
    Eur J Gynaecol Oncol; 1994; 15(5):393-5. PubMed ID: 7828611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iatrogenic endometrial megapolyps in women with breast carcinoma.
    Berezowsky J; Chalvardjian A; Murray D
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian volume in postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Altaras MM; Beyth Y; Zalel Y; Shapira J; Yigael D; Tepper R
    Gynecol Oncol; 1997 Jan; 64(1):105-8. PubMed ID: 8995556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometriosis and the development of malignant tumours of the pelvis. A review of literature.
    Van Gorp T; Amant F; Neven P; Vergote I; Moerman P
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):349-71. PubMed ID: 15157647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrioid adenocarcinoma with squamous differentiation arising from ureteral endometriosis in a patient with no history of gonadal endometriosis.
    Salerno MG; Masciullo V; Naldini A; Zannoni GF; Vellone V; Scambia G
    Gynecol Oncol; 2005 Dec; 99(3):749-52. PubMed ID: 16226301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy-a case to illustrate features on magnetic resonance imaging.
    Kraft JK; Hughes T
    Clin Radiol; 2006 Feb; 61(2):198-201. PubMed ID: 16439226
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
    Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
    Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial cancer within tamoxifen-related polyps in patients with breast cancer.
    Tate S; Yamazawa K; Sekiya S
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):769-70. PubMed ID: 15255851
    [No Abstract]   [Full Text] [Related]  

  • 40. Not all endometriosis is benign.
    Byrd L; Slade R; Mamtora H
    J Obstet Gynaecol; 2004 Apr; 24(3):330-1. PubMed ID: 15203654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.